12 March 2023: Articles
Successful Pregnancy in a 29-Year-Old G3P2 Shortly After Unilateral Pneumonectomy and Systemic Chemotherapy for Lung Cancer: A Case Report
Diagnostic / therapeutic accidents, Unusual setting of medical care, Rare diseaseDaniah Aloufi1ABD, Saeed Baradwan2CDEF*, Samira AlTurkistany3CDE, Ghaidaa Hakeem2ABCDEF
Am J Case Rep 2023; 24:e939227
BACKGROUND: The incidence of tumors during pregnancy, generally, is very uncommon. The incidence of lung cancer during pregnancy, specifically, is exceedingly rare. Several investigations have documented favorable maternal-fetal outcomes for later pregnancies after pneumonectomy due to non-cancer-related causes (mostly progressive pulmonary tuberculosis). However, very little is known about maternal-fetal outcomes for future conceptions after pneumonectomy due to cancer-related causes and subsequent chemotherapy cycles. This is an important knowledge gap in the literature that needs to be filled.
CASE REPORT: A 29-year-old woman (non-smoker) had adenocarcinoma of the left lung, which was discovered during her pregnancy at 28 weeks of gestation. She underwent an urgent lower-segment transverse cesarean section at 30 weeks and subsequently underwent unilateral pneumonectomy and then completed her planned adjuvant chemotherapy. The patient was incidentally found to be pregnant at 11 weeks of gestation (roughly 5 months after the completion of her adjuvant chemotherapy cycles). Hence, the conception was estimated to have happened roughly 2 months after the completion of her chemotherapy cycles. A multidisciplinary team was formed and it was decided to keep her pregnancy as there was no clear medical reason to terminate it. The pregnancy was carried out to term gestation at 37+4 weeks with close monitoring, and she delivered a healthy baby via lower-segment transverse cesarean section.
CONCLUSIONS: Successful pregnancy after unilateral pneumonectomy and adjuvant systematic chemotherapy is rarely reported. The maternal-fetal outcomes after unilateral pneumonectomy and systematic chemotherapy need expertise and a multidisciplinary approach to prevent complications.
Keywords: Adenocarcinoma, Neoplasms, Pneumonectomy, Pregnancy
Lung cancer is a common cause of cancer-related death worldwide among females . Its occurrence is rare (about <5%) among females who are less than 40 to 45 years old . Adenocarcinoma is the most common histological type of lung cancer among females . The prevalence of lung cancer during pregnancy is exceedingly rare, and it is estimated to affect about 0.1% of all pregnancies [3,4]. The most recent review in 2016 by Mitrou et al reported a total of 70 cases of lung cancer during pregnancy . Generally speaking, lung resection is the standard surgical treatment for lung cancer, and postoperative chemotherapy has been demonstrated to prolong overall survival .
Pneumonectomy is a surgical procedure that involves the removal of 1 entire lung, and it is different from lobectomy and other related procedures. The indications of pneumonectomy are numerous and include trauma, infection (eg, tuberculosis), and malignancy (eg, non-small cell lung cancer). There are several published reports of concurrent pneumonectomy for progressive pulmonary tuberculosis  and invasive chondrosarcoma of the rib  during pregnancy, which were followed by a normal birth during the same course of pregnancy. Moreover, several investigations have documented favorable maternal-fetal outcomes for later pregnancies after pneumonectomy due to non-cancer-related causes, most of which were secondary to progressive pulmonary tuberculosis [8–10]. However, very little is known about maternal-fetal outcomes for future conceptions after pneumonectomy due to cancer-related causes (eg, squamous cell carcinoma) and subsequent chemotherapy regimens. This is an important knowledge gap in the literature that needs to be filled.
Herein, we report the maternal-fetal outcomes of a 29-year-old Saudi woman who conceived after unilateral pneumonectomy and adjuvant chemotherapy.
A 29-year-old Saudi woman, G3P2, at 11 weeks of a spontaneous singleton pregnancy, presented to our maternal-fetal medicine clinic for routine follow-up. She was a known case of adenocarcinoma of the left lung 2 years ago, which was discovered during her second pregnancy at 28 weeks of gestation after an episode of hemoptysis. During the work-up, a lung mass was found and a biopsy confirmed lung adenocarcinoma. She underwent an urgent lower-segment transverse cesarean section at 30 weeks due to the urgent need for lung surgery. She immediately underwent left pneumonectomy, and 4 weeks later after surgery she received 6 cycles of adjuvant chemotherapy (cisplatin and pemetrexed), which was completed over 7 months. The histopathology of her left lung revealed poorly-differentiated invasive adenocarcinoma, grade III. At the molecular level, the malignant cells were wild-type for epidermal growth factor receptor (EGFR), but stained positive (60%) for programmed cell death ligand 1 (PD-L1). The patient was not planning on conceiving and she was not on proper contraception, as she believed that her fertility would automatically decline during chemotherapy. Nevertheless, she was incidentally found to be pregnant at 11 weeks of gestation at the time of attendance to the obstetric clinic (roughly 5 months after the completion of her adjuvant chemotherapy cycles). Hence, the conception was estimated to have happened roughly 2 months after the completion of her chemotherapy cycles.
At presentation to the clinic, she was asymptomatic. The obstetric history was remarkable for a previous cesarean delivery secondary to her condition of lung cancer 2 years ago; otherwise, she had 1 term uncomplicated normal vaginal delivery. Her family history and social history were unremarkable. The patient and her husband were both non-smokers. Her menarche began at 13 years old, with subsequent regular cycles.
An ultrasound examination showed a single viable intrauterine pregnancy corresponding to 11+4 weeks and normal nuchal translucency of 1.2 mm (37%). A multidisciplinary approach was introduced, with contributions from maternal-fetal medicine, medical oncology, and pulmonary teams to plan her management. Following a discussion of the benefits and risks, it was decided to keep her pregnancy because there was no clear medical reason to terminate it as the patient had stage II-B adenocarcinoma and had recently completed the full proper treatment. However, as the 5-year recurrence rate for this specific tumor is high, the management team recommended close monitoring and regular follow-up of the patient with different teams.
The baseline computed tomography (CT) chest and abdomen without contrast displayed complete opacification of the left hemithorax with a shift of the cardiac silhouette towards the left side. The right lung was clear with no sizable right effusion.
At 19 weeks of gestation, a CT chest revealed no signs of recurrence or metastasis; however, the possibility of missing smaller metastasis spots could not be confidently excluded because the imaging investigations were done without contrast (Figure 1). Her antenatal visit was uneventful. An obstetric ultrasound exam demonstrated normal anatomy and growth scan. Laboratory work-up, including complete blood count, in addition to renal, and hepatic function tests, revealed normal results. An adult echocardiogram showed normal findings.
The lower-segment transverse cesarean section was performed at 37+4 weeks, since the patient had 1 previous cesarean section and refused vaginal birth after cesarean delivery. The baby weighed 2495 g with an Apgar score of 8 and 9 at 1 and 5 minutes, respectively. The postpartum interval was not complicated. After delivery, a CT chest and abdomen showed no signs of recurrence or metastasis. At 8-weeks follow-up, the management team inserted a non-hormonal intrauterine device (copper-based) for contraception. The patient had returned to her normal daily activities and planned follow up with medical oncology and pulmonary teams.
The first case of lung cancer during pregnancy was reported in the early 1950s . The incidence of tumors during pregnancy, generally, is very uncommon. The incidence of lung cancer during pregnancy, specifically, is exceedingly low [3,4]. In the present case report, our non-smoker, 29-year-old patient was diagnosed with adenocarcinoma of the lung during her second pregnancy and underwent urgent cesarean section to perform unilateral pneumonectomy, which was followed by adjuvant chemotherapy. In consideration of the underlying malignancy, the medical oncologist prevented the patient from using any hormonal contraception (eg, pills, patches, or hormone-based intrauterine devices) so as to not increase the potential risk of thromboembolic events. The patient was counselled about the potential problems of future conception. Also, the use of physical condoms as a method of contraception was advised and not prohibited. Nonetheless, around 5 months after the completion of the adjuvant chemotherapy cycles, the patient was found to be pregnant at 11 weeks of gestation. A recent review revealed that almost 50% of patients diagnosed with lung cancer during pregnancy were treated during the post-partum period, whereas 24% of the patients were treated during the course of the pregnancy . This observation indicates that cancer treatment during pregnancy may not affect pregnancy in terms of maternal-fetal outcomes. Also, it was reported that almost all patients with lung cancer during pregnancy were found to be positive for EGFR mutation , which was not the case in our patient.
The patient was referred to our maternal-fetal medicine service and underwent CT without contrast. The literature suggests that CT does not appear to increase the hazard of spontaneous abortion or congenital deformities. However, CT may potentially increase the likelihood of developing pediatric malignancies . Also, while intravenous gadolinium is contra-indicated during pregnancy, iodinated contrast appears to be safe during pregnancy . In our case, it was decided that there was no need for any obstetric intervention, as she had completed her adjuvant therapy.
During pregnancy, several physiologic alterations happen, including increased minute ventilation, compensated respiratory alkalosis, and low expiratory reserve volume. Pregnant women with respiratory diseases other than chronic respiratory insufficiency or pulmonary hypertension can actually tolerate pregnancy very well . Moreover, a large series of nearly 80 patients established that unilateral pneumonectomy can result in a normal obstetric history and life expectancy .
It was reported that the administration of systemic chemo-therapy during the first trimester should be avoided owing to the serious consequences to the fetus, whereas several chemotherapy or combination drugs could be safely administered during the second and third trimesters [15–17]. Our patient presented to our center at the end of the first trimester, and she had already completed her treatment cycles. This also may indicate that her combined therapy had no adverse impact on her pregnancy or fetus.
Pulmonary malignancy during pregnancy is rarely reported and the associated maternal-fetal outcomes after one-sided pneumonectomy and adjuvant chemotherapy are underreported. Herein, we presented a case of incidental conception shortly after performing unilateral pneumonectomy and completing adjuvant chemotherapy. Overall, her pregnancy did not seem to be adversely affected by the unilateral pneumonectomy and adjuvant chemotherapy. She carried out her pregnancy and delivered by cesarean section at 37 weeks and 4 days of gestation for an obstetric indication. Overall, conception after unilateral pneumonectomy and adjuvant chemotherapy is not strongly contraindicated, but it is not encouraged.
1.. Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer statistics, 2022: Cancer J Clin, 2022; 72(1); 7-33
2.. Domagala-Kulawik J, Trojnar A, Lung cancer in women in 21th century: J Thorac Dis, 2020; 12(8); 4398-410
3.. Pereg D, Koren G, Lishner M, Cancer in pregnancy: Gaps, challenges and solutions: Cancer Treat Rev, 2008; 34(4); 302-12
4.. Mitrou S, Petrakis D, Fotopoulos G, Lung cancer during pregnancy: A narrative review: J Adv Res, 2016; 7(4); 571-74
5.. Thai AA, Solomon BJ, Sequist LV, Lung cancer: Lancet, 2021; 398(10299); 535-54
6.. Thompson SA, Bressler S, Pneumonectomy for pulmonary tuberculosis in a woman 6 months pregnant, followed by a normal birth: Surgery, 1949; 26(2); 242
7.. Kapdagli M, Erus S, Tanju S, Dilege S, Extensive chest wall resection, reconstruction and right pneumonectomy in a 24-week pregnant patient: Lung Cancer, 2018; 122; 7-9
8.. Laros KD, The postpneumonectomy mother. Pregnancy, delivery and motherhood in 80 patients followed through more than 20 years after surgery: Respiration, 1980; 39(4); 185-87
9.. Laros CD, Pregnancy after pneumonectomy for pulmonary tuberculosis; Analysis of a collected series of seventy-four pregnancies in the Netherlands: Am Rev Tuberc, 1958; 78(4); 563-69
10.. Mishanich IuV, [2 cases of pregnancy and labor after pneumonectomy for pulmonary tuberculosis]: Pediatr Akus Ginekol, 1969; 4; 61 [in Ukranian]
11.. Barr JS, Placental metastases from a bronchial carcinoma: J Obstet Gynaecol Br Emp, 1953; 60(6); 895-97
12.. Schmidt MH, Computed tomography in pregnant patients: J Med Imaging Radiat Sci, 2009; 40(3); 100-4
13.. Chen MM, Coakley FV, Kaimal A, Laros RK, Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation: Obstet Gynecol, 2008; 112(2 Pt 1); 333-40
14.. Wise RA, Polito AJ, Krishnan V, Respiratory physiologic changes in pregnancy: Immunol Allergy Clin North Am, 2006; 26(1); 1-12
15.. Azim HA, Peccatori FA, Pavlidis N, Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors: Cancer Treat Rev, 2010; 36(2); 101-9
16.. Azim HA, Pavlidis N, Peccatori FA, Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors: Cancer Treat Rev, 2010; 36(2); 110-21
17.. Amant F, Han SN, Gziri MM, Chemotherapy during pregnancy: Curr Opin Oncol, 2012; 24(5); 580-86
21 March 2023 : Case reportKidney Transplantation from a Deceased Donor with COVID-19 Ad26.COV2-S Vaccine-Induced Thrombotic Thrombocy...
Am J Case Rep In Press; DOI: 10.12659/AJCR.938730
21 March 2023 : Case reportClassical Presentation of Disseminated Blastomycosis in a 44-Year-Old Healthy Man 3 Months After Diagnosis ...
Am J Case Rep In Press; DOI: 10.12659/AJCR.938659
22 February 2023 : Case reportA 30-Year-Old Woman with an 8-Week History of Anxiety, Depression, Insomnia, and Mild Cognitive Impairment ...
Am J Case Rep In Press; DOI: 10.12659/AJCR.938732
22 February 2023 : Case reportMultidrug-Resistant Kocuria rosea and Methicillin-Resistant Staphylococcus aureus Co-Infection in a Nigeria...
Am J Case Rep In Press; DOI: 10.12659/AJCR.938761
27 Mar 2023 : Case reportChest Tightness with Cycling Turned Out To Be Pneumomediastinum
Am J Case Rep In Press; DOI: 10.12659/AJCR.939170
27 Mar 2023 : Case reportAtypical Hemolytic Uremic Syndrome in a Pregnant Patient with a Thrombomodulin Gene Variant Treated with Pl...
Am J Case Rep In Press; DOI: 10.12659/AJCR.938896
27 Mar 2023 : Case reportBartonella Neuroretinitis: There Is More to Cat Scratch Disease than Meets the Eye
Am J Case Rep In Press; DOI: 10.12659/AJCR.938380
24 Mar 2023 : Case reportSplinter Cataract in Patients with Keratoconus and Frequent Eye Rubbing: A Novel Finding
Am J Case Rep In Press; DOI: 10.12659/AJCR.939082
Most Viewed Current Articles
13 Jul 2022 : Case reportWhistling Scrotum: An Unusual Presentation of Pneumomediastinum in the Setting of an Open Scrotal Wound
Am J Case Rep 2022; 23:e936441
06 Dec 2021 : Case reportLipedema Can Be Treated Non-Surgically: A Report of 5 Cases
Am J Case Rep 2021; 22:e934406
23 Feb 2022 : Case reportPenile Necrosis Associated with Local Intravenous Injection of Cocaine
Am J Case Rep 2022; 23:e935250
07 Dec 2021 : Case reportEdwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Fac...
Am J Case Rep 2021; 22:e934347